M. Grainge

First name
M.
Last name
Grainge
Abhishek, A., Grainge, M., Card, T., Williams, H. C., Taal, M. W., Aithal, G. P., et al. (2024). Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. Rmd Open, 10. http://doi.org/10.1136/rmdopen-2023-003980
Walker, A. J., Grainge, M., Bates, T. E., & Card, T. R. (2012). Survival of glioma and colorectal cancer patients using tricyclic antidepressants post-diagnosis. Cancer Causes Control. http://doi.org/10.1007/s10552-012-0073-0
Rees, F., Doherty, M., Grainge, M., Davenport, G., Lanyon, P., & Zhang, W. (2016). The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-206334
Rees, F., Doherty, M., Grainge, M., Lanyon, P., Davenport, G., & Zhang, W. (2016). Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012. Arthritis Care Res (Hoboken). http://doi.org/10.1002/acr.22751
Nakafero, G., Grainge, M., Valdes, A., Townsend, N., Mallen, C., Zhang, W., et al. (2019). Do beta-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink. BMJ Open. http://doi.org/10.1136/bmjopen-2019-032050